NO20003764D0 - New <beta> -carboline compounds, process of their preparation and pharmaceutical compositions containing them - Google Patents
New <beta> -carboline compounds, process of their preparation and pharmaceutical compositions containing themInfo
- Publication number
- NO20003764D0 NO20003764D0 NO20003764A NO20003764A NO20003764D0 NO 20003764 D0 NO20003764 D0 NO 20003764D0 NO 20003764 A NO20003764 A NO 20003764A NO 20003764 A NO20003764 A NO 20003764A NO 20003764 D0 NO20003764 D0 NO 20003764D0
- Authority
- NO
- Norway
- Prior art keywords
- beta
- preparation
- new
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9909576A FR2796644B1 (en) | 1999-07-23 | 1999-07-23 | NOVEL BETA-CARBOLINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003764D0 true NO20003764D0 (en) | 2000-07-21 |
NO20003764L NO20003764L (en) | 2001-01-24 |
Family
ID=9548447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003764A NO20003764L (en) | 1999-07-23 | 2000-07-21 | New <beta> -carboline compounds, process of their preparation and pharmaceutical compositions containing them |
Country Status (16)
Country | Link |
---|---|
US (1) | US6350757B1 (en) |
EP (1) | EP1070716A1 (en) |
JP (1) | JP2001072679A (en) |
KR (1) | KR20010049859A (en) |
CN (1) | CN1282743A (en) |
AU (1) | AU762958B2 (en) |
BR (1) | BR0003105A (en) |
CA (1) | CA2314473A1 (en) |
EA (1) | EA004140B1 (en) |
FR (1) | FR2796644B1 (en) |
HU (1) | HUP0002843A3 (en) |
MX (1) | MXPA00007058A (en) |
NO (1) | NO20003764L (en) |
NZ (1) | NZ505903A (en) |
PL (1) | PL341549A1 (en) |
ZA (1) | ZA200003702B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74826C2 (en) | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
US20040253891A1 (en) * | 2000-09-12 | 2004-12-16 | Schierenbeck Alan W. | Composite structure for protective garment |
TWI329111B (en) | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
EP1628977B1 (en) * | 2003-04-29 | 2008-11-12 | Oscient Pharmaceuticals | ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES |
ES2427166T3 (en) * | 2003-06-23 | 2013-10-29 | Ono Pharmaceutical Co., Ltd. | Novel tricyclic heterocyclic compound |
US20050143371A1 (en) * | 2003-07-23 | 2005-06-30 | Pharmacia Corporation | Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
CA2554150A1 (en) | 2004-01-23 | 2005-08-04 | Chiron Corporation | Tetrahydrocarboline compounds as anticancer agents |
DK1737461T3 (en) | 2004-03-15 | 2013-03-18 | Ptc Therapeutics Inc | CARBOLIN DERIVATIVES FOR INHIBITING ANGIOGENESES |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
AR051780A1 (en) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | FUSIONED RING COMPOUNDS CONTAINING NITROGEN AND USING THEMSELVES |
US7964726B2 (en) | 2004-12-22 | 2011-06-21 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
FR2901795A1 (en) * | 2006-05-30 | 2007-12-07 | Fourtillan Snc | DERIVATIVES OF PYRIMIDINO [1 ', 6'-1,2] PYRIDO [3,4-B] INDOLES AND THEIR USE IN THERAPEUTICS |
FR2908768A1 (en) * | 2006-06-19 | 2008-05-23 | Fourtillan Snc | DERIVATIVES OF 3H, 11H-OXAZOLO (3 ', 4': 1,2) PYRIDO (3,4-b) INDOLE AND THEIR USE IN THERAPEUTICS |
FR2912405A1 (en) * | 2007-02-08 | 2008-08-15 | Fourtillan Snc | DERIVATIVES OF IMIDAZO [1 ', 5': 1,6] PYRIDO [3,4-B] INDOLES AND THEIR USE IN THERAPEUTICS |
AU2008302751A1 (en) * | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
JP2011505373A (en) * | 2007-11-30 | 2011-02-24 | ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド | Bicyclic PPAT inhibitors as antibacterial agents |
US8648077B2 (en) * | 2008-03-12 | 2014-02-11 | Intra-Cellular Therapies, Inc. | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals |
US8338447B2 (en) * | 2008-03-24 | 2012-12-25 | Medivation Technologies, Inc. | Pyrido[3,4-B]indoles and methods of use |
DE102008025893B4 (en) * | 2008-05-26 | 2014-09-18 | Technische Universität Dresden | Process for the preparation of fatty acid amides with saturated, unsaturated or hydroxy fatty acids |
JP5791611B2 (en) * | 2009-09-23 | 2015-10-07 | メディベイション テクノロジーズ, インコーポレイテッド | Pyrido [3,4-B] indole and methods of use |
BR112012006646A2 (en) * | 2009-09-23 | 2019-09-24 | Medivation Technologies Inc | compound, pharmaceutical composition, method of treating a cognitive disorder, psychotic disorder, neurotransmitter mediated disorder or a neuronal disorder and kit |
US8791132B2 (en) | 2011-02-18 | 2014-07-29 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
JP6107650B2 (en) | 2011-03-18 | 2017-04-05 | 小野薬品工業株式会社 | Tetrahydrocarboline derivative |
KR101534523B1 (en) * | 2013-04-30 | 2015-07-09 | 경희대학교 산학협력단 | Cosmetic Composition for Skin Whitening Comprising 1,2,3,4-Tetrahydro-6-methoxy-1-oxo-beta-carboline |
WO2014191726A1 (en) * | 2013-05-28 | 2014-12-04 | Astrazeneca Ab | Chemical compounds |
US11485734B2 (en) | 2018-10-02 | 2022-11-01 | Northwestern University | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT2C) |
US10947253B2 (en) | 2019-08-05 | 2021-03-16 | Ankh Life Sciences Limited | Fused polycyclic dimers |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR205452A1 (en) * | 1973-12-06 | 1976-05-07 | Endo Lab | METHOD TO PREPARE NEW TRANS-2, 3, 4, 4A, 5, 9B-HEXAHYDRO-5-PHENYL-1H-PYRID (4,3-B) INDOLES |
FR2455044A1 (en) * | 1979-04-26 | 1980-11-21 | Synthelabo | PYRIDO-INDOLES AND THEIR APPLICATION IN THERAPEUTICS |
JP2527319B2 (en) * | 1986-12-25 | 1996-08-21 | 川研ファインケミカル株式会社 | Method for producing 7-bromo-β-carboline derivative |
US5300645A (en) * | 1993-04-14 | 1994-04-05 | Eli Lilly And Company | Tetrahydro-pyrido-indole |
EP0620222A3 (en) * | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tetrahydro-beta-carbolines. |
US5688807A (en) * | 1994-03-11 | 1997-11-18 | Eli Lilly And Company | Method for treating 5HT2B receptor related conditions |
US5663178A (en) * | 1995-02-06 | 1997-09-02 | Eli Lilly And Company | Tetrahydro-beta carbolines |
-
1999
- 1999-07-23 FR FR9909576A patent/FR2796644B1/en not_active Expired - Fee Related
-
2000
- 2000-07-19 MX MXPA00007058A patent/MXPA00007058A/en unknown
- 2000-07-19 JP JP2000218942A patent/JP2001072679A/en active Pending
- 2000-07-19 PL PL00341549A patent/PL341549A1/en not_active Application Discontinuation
- 2000-07-20 CA CA002314473A patent/CA2314473A1/en not_active Abandoned
- 2000-07-21 HU HU0002843A patent/HUP0002843A3/en unknown
- 2000-07-21 NZ NZ505903A patent/NZ505903A/en unknown
- 2000-07-21 CN CN00121615A patent/CN1282743A/en active Pending
- 2000-07-21 US US09/621,742 patent/US6350757B1/en not_active Expired - Fee Related
- 2000-07-21 EA EA200000700A patent/EA004140B1/en not_active IP Right Cessation
- 2000-07-21 EP EP00402073A patent/EP1070716A1/en not_active Withdrawn
- 2000-07-21 AU AU48769/00A patent/AU762958B2/en not_active Ceased
- 2000-07-21 ZA ZA200003702A patent/ZA200003702B/en unknown
- 2000-07-21 NO NO20003764A patent/NO20003764L/en unknown
- 2000-07-24 BR BR0003105-4A patent/BR0003105A/en not_active IP Right Cessation
- 2000-07-24 KR KR1020000042401A patent/KR20010049859A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1282743A (en) | 2001-02-07 |
NZ505903A (en) | 2001-08-31 |
JP2001072679A (en) | 2001-03-21 |
NO20003764L (en) | 2001-01-24 |
KR20010049859A (en) | 2001-06-15 |
FR2796644B1 (en) | 2001-09-07 |
PL341549A1 (en) | 2001-01-29 |
US6350757B1 (en) | 2002-02-26 |
HUP0002843A2 (en) | 2001-04-28 |
ZA200003702B (en) | 2001-05-21 |
BR0003105A (en) | 2001-03-13 |
FR2796644A1 (en) | 2001-01-26 |
EP1070716A1 (en) | 2001-01-24 |
EA200000700A2 (en) | 2001-02-26 |
MXPA00007058A (en) | 2002-04-24 |
HU0002843D0 (en) | 2000-09-28 |
AU762958B2 (en) | 2003-07-10 |
CA2314473A1 (en) | 2001-01-23 |
EA004140B1 (en) | 2004-02-26 |
EA200000700A3 (en) | 2001-04-23 |
HUP0002843A3 (en) | 2001-07-30 |
AU4876900A (en) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003764D0 (en) | New <beta> -carboline compounds, process of their preparation and pharmaceutical compositions containing them | |
NO996250L (en) | New Hydrazide Compounds, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20022285L (en) | New <alfa> amino acid compounds, process of their preparation and pharmaceutical compositions containing them | |
NO20015016D0 (en) | New polymorphic forms of an antidiabetic agent; process for their preparation and pharmaceutical compositions containing them | |
NO971862L (en) | Novel Inhibitors of Metalloprotease, Process of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20013254L (en) | New Diphenylurea Compounds, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20010522L (en) | New piperidine-4-sulfonamide compounds, process of their preparation and pharmaceutical compositions containing them | |
NO20014945L (en) | New Cyclone Butenedione Compounds, Methods of Their Preparation and Pharmaceutical Compositions Containing Them | |
NO20026154D0 (en) | New Substituted Phthalides, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20013206L (en) | New 1,1- and 1,2-disubstituted cyclopropane compounds, process of their preparation, and pharmaceutical compositions containing them | |
NO20010305L (en) | New Benzenesulfonamide Compounds, Processes for their Preparation and Pharmaceutical Compositions Containing Them | |
NO20021330L (en) | New Indoindolone Compounds, Methods of their Preparation, and Pharmaceutical Compositions Containing Them | |
NO20031643L (en) | Novel aminotriazolone compounds, processes for their preparation and pharmaceutical compositions containing them | |
NO20021198D0 (en) | New isoindoloindolone compounds, process of their preparation and pharmaceutical compositions containing them | |
NO20013710L (en) | New Benzothiadiazine Compounds, Methods of their Preparation, and Pharmaceutical Compositions Containing Them | |
NO20016069D0 (en) | Novel bicyclic amino-pyrazinone compounds, process of their preparation, and pharmaceutical compositions containing them | |
DK1150970T3 (en) | (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, process for their preparation and pharmaceutical compositions containing them | |
NO961677D0 (en) | New Cyclohexane Compounds, Methods of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20023389D0 (en) | New Benzenesulfonamide Compounds, Methods of their Preparation, and Pharmaceutical Compositions Containing Them | |
NO20023409D0 (en) | New N-Benzylpiperazine Compounds, Processes of their Preparation and Pharmaceutical Compositions Containing Them | |
NO20011862D0 (en) | Novel heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, process of their preparation and pharmaceutical compositions containing them | |
NO20010801D0 (en) | Novel 6-amino- or 6-hydroazino-sulfonyl-3-quinolynylphosphonic acid compound, process for their preparation and pharmaceutical compositions containing them | |
NO20010800L (en) | New 6-sulfamoyl-3-quinolylphosphonic acid compounds, process of their preparation and pharmaceutical compositions containing them | |
NO20025393L (en) | Optis 2-aminotetraline derivatives, process for their preparation and therapeutic use of pharmaceutical use of pharmaceutical compositions containing them | |
NO20022794L (en) | New Indoindolone Compounds, Methods of their Preparation, and Pharmaceutical Compositions Containing Them |